-5%
Anulid 600 is an antibiotic used in the treatment of serious bacterial infections, particularly those affecting the lungs (e.g., pneumonia), skin, and soft tissues. It belongs to the oxazolidinone class of antibiotics and is effective against infections caused by certain types of bacteria, including resistant strains. Regular monitoring of blood counts is recommended, as Anulid 600 may cause myelosuppression, including anemia, leukopenia, thrombocytopenia, or pancytopenia, particularly if taken for more than 10–14 days.
Anulid 600 is prescribed for the management of the following conditions:
- Community-acquired pneumonia
- Nosocomial pneumonia (hospital-acquired pneumonia)
- Complicated skin and skin structure infections
- Vancomycin-resistant Enterococcus faecium (VRE) infections
- Methicillin-resistant Staphylococcus aureus (MRSA) infections
The active ingredient in Anulid 600 is Linezolid, which is a bacteriostatic oxazolidinone antibiotic. It works by inhibiting ribosomal protein synthesis, which is essential for bacterial growth and function. By targeting this process, Anulid 600 effectively halts bacterial growth and prevents further spread of the infection.